Skip to main content
Monday, November 16, 2026Nov 16

GOP leaders set for House vote on medical research bill

FILE - In this Spet. 19, 2015, file photo Rep. Fred Upton, R-Mich., is seen during a congressional panel at the 2016 Mackinac Republican Leadership Conference in Mackinac Island, Mich. Republican leaders are ready to push through the House a compromise medical research bill that’s prompted complaints from Democrats and consumer groups but seems all but certain to sail through Congress because it contains victories for both parties and the White House. “We feel that we’re on good footing,” Upton, chairman of the House Energy and Commerce Committee, said about the bill’s prospects in both the House and Senate. (AP Photo/Carlos Osorio, File)
FILE - In this Spet. 19, 2015, file photo Rep. Fred Upton, R-Mich., is seen during a congressional panel at the 2016 Mackinac Republican Leadership Conference in Mackinac Island, Mich. Republican leaders are ready to push through the House a compromise medical research bill that’s prompted complaints from Democrats and consumer groups but seems all but certain to sail through Congress because it contains victories for both parties and the White House. “We feel that we’re on good footing,” Upton, chairman of the House Energy and Commerce Committee, said about the bill’s prospects in both the House and Senate. (AP Photo/Carlos Osorio, File)

WASHINGTON (AP) – Republican leaders are ready to push through the House a compromise medical research bill that’s prompted complaints from Democrats and consumer groups but seems all but certain to sail through Congress with momentum built by victories that it delivers for both parties and the White House.

The legislation envisions spending $6.3 billion over the coming decade, including $4.8 billion for National Institutes of Health research. States would get $1 billion over the next two years for preventing and treating abuse of addictive drugs like opioids, a surging problem in red and blue states alike, while the Food and Drug Administration would get $500 million to streamline approval processes for drugs and medical devices.

On the eve of the House’s scheduled Wednesday vote, the White House sent a letter to lawmakers voicing strong support for the measure, all but guaranteeing congressional approval. Addressing worries by some Democrats, the letter said administration officials would act swiftly “to ensure that the funds in the bill would be disbursed quickly and effectively so we can begin to address these important public health challenges.”

Senate consideration was expected next week.

“We feel that we’re on good footing,” Rep. Fred Upton, R-Mich., chairman of the House Energy and Commerce Committee, said of the bill’s prospects in both the House and Senate.